James Wells, PhD, cofounder of the South San Francisco-based pharmaceutical company Sunesis and a pioneer in developing new drug discovery and protein engineering technologies, has been appointed professor in both the schools of pharmacy and medicine at UCSF and will also direct a new center ...

Among African-Americans with prostate cancer, a tumor-suppressing gene called GSTP1 is inactivated at a rate 3.5 times higher than among Caucasians, according to a study conducted at the San Francisco VA Medical Center (SFVAMC). "This could be one of the mechanisms for the higher incidence ...

Organ transplant recipients have a high risk of developing skin cancer, but information about this deadly link has not been readily available to patients. Now UCSF Medical Center is offering a program to remedy the problem. The Department of Dermatology and the Division of Transplant ...

Binding gold nanoparticles to a specific antibody for cancer cells could make cancer detection much easier, say medical researchers from the University of California, San Francisco and Georgia Institute of Technology. The researchers are a father and son, working together on opposite coasts. Their study ...

In a major step to provide a safe and healthy environment, UCSF will significantly reduce on-campus smoking areas to protect human health. With the exception of only a few, small designated areas for patients and visitors, all University-owned or leased property will be smoke-free effective ...

A new study by UCSF School of Nursing researchers shows that Philip Morris sought to enhance its image by supporting Food and Drug Administration regulation of tobacco. Philip Morris was among major U.S. tobacco companies that previously sued the FDA when it attempted to regulate ...